Wall Street PR

Steve Hackney

Exelixis, Inc. (NASDAQ:EXEL): Not Coming Soon

Boston, MA 03/26/2014 (wallstreetpr) – Exelixis, Inc. (NASDAQ:EXEL)’s prostate cancer drug candidate which showed positive results in the Phase II of clinical trial will not come

Exelixis, Inc. (NASDAQ:EXEL): Not Coming Soon

Boston, MA 03/26/2014 (wallstreetpr) – Exelixis, Inc. (NASDAQ:EXEL)’s prostate cancer drug candidate which showed positive results in the Phase II of clinical trial will not come